44 related articles for article (PubMed ID: 35220194)
1. The MC1R r allele does not increase melanoma risk in MITF E318K carriers.
Wallingford CK; Demeshko A; Krishnakripa AK; Smit DJ; Duffy DL; Betz-Stablein B; Pflugfelder A; Jagirdar K; Holland E; Mann GJ; Primiero CA; Yanes T; Malvehy J; Badenas C; Carrera C; Aguilera P; Olsen CM; Ward SV; Haass NK; Sturm RA; Puig S; Whiteman DC; Law MH; Cust AE; Potrony M; Soyer HP; McInerney-Leo AM
Br J Dermatol; 2023 May; 188(6):770-776. PubMed ID: 36879448
[TBL] [Abstract][Full Text] [Related]
2. MITF E318K: A rare homozygous case with multiple primary melanoma.
Wallingford CK; Maas EJ; Howard A; DeBortoli E; Bhanja D; Lee K; Mothershaw A; Jagirdar K; Willett R; Betz-Stablein B; Sturm RA; Soyer HP; McInerney-Leo AM
Pigment Cell Melanoma Res; 2024 Jan; 37(1):68-73. PubMed ID: 37635363
[TBL] [Abstract][Full Text] [Related]
3. DNA damage remodels the MITF interactome to increase melanoma genomic instability.
Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
[TBL] [Abstract][Full Text] [Related]
4. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma.
Hubert JN; Suybeng V; Vallée M; Delhomme TM; Maubec E; Boland A; Bacq D; Deleuze JF; Jouenne F; Brennan P; McKay JD; Avril MF; Bressac-de Paillerets B; Chanudet E
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34067022
[No Abstract] [Full Text] [Related]
6. DNA damage-induced interaction between a lineage addiction oncogenic transcription factor and the MRN complex shapes a tissue-specific DNA Damage Response and cancer predisposition.
Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey T; Fillipakopoulos P; White R; Goding CR
bioRxiv; 2023 Apr; ():. PubMed ID: 37131595
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.
Shen A; Arbesman M; Lodha R; Rayman P; Bungo B; Ni Y; Chan T; Gastman B; Ko J; Diaz-Montero CM; Arbesman J; Funchain P
Clin Cancer Res; 2024 Feb; 30(3):564-574. PubMed ID: 38032355
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanisms of MITF regulation and melanoma predisposition identified in a mouse suppressor screen.
Vu HN; Valdimarsson MM; Sigurbjörnsdóttir S; Bergsteinsdóttir K; Debbache J; Bismuth K; Swing DA; Hallsson JH; Larue L; Arnheiter H; Copeland NG; Jenkins NA; Heidarsson PO; Steingrímsson E
bioRxiv; 2023 Aug; ():. PubMed ID: 37786677
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Vulvar Melanoma: A Case Series.
Sánchez-Prieto M; Fargas F; Tresserra F; González-Cao M; Baulies S; Fábregas R
Case Rep Oncol; 2021; 14(2):1144-1151. PubMed ID: 34413746
[TBL] [Abstract][Full Text] [Related]
10. Novel gene variant for melanoma predisposition.
Das M
Lancet Oncol; 2018 Apr; ():. PubMed ID: 29681537
[No Abstract] [Full Text] [Related]
11. Current Trends in Mucosal Melanomas: An Overview.
Santeufemia DA; Palmieri G; Miolo G; Colombino M; Doro MG; Frogheri L; Paliogiannis P; Capobianco G; Madonia M; Cossu A; Lo Re G; Corona G
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900152
[TBL] [Abstract][Full Text] [Related]
12. Vulvar Malignant Melanoma: A Narrative Review.
Falcicchio G; Vinci L; Cicinelli E; Loizzi V; Arezzo F; Silvestris E; Resta L; Serio G; Cazzato G; Mastronardi M; Mongelli M; Marinaccio M; Cormio G
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358637
[TBL] [Abstract][Full Text] [Related]
13. Vulvar Melanoma in association with germline MITF p.E318K variant.
Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks associated with the germline MITF(E318K) variant.
Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
17. A germline oncogenic MITF mutation and tumor susceptibility.
Paillerets BB; Lesueur F; Bertolotto C
Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
[TBL] [Abstract][Full Text] [Related]
18. Pathways from senescence to melanoma: focus on MITF sumoylation.
Leclerc J; Ballotti R; Bertolotto C
Oncogene; 2017 Nov; 36(48):6659-6667. PubMed ID: 28825724
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
